A decreased albumin level has been interpreted as a possible consequence of tumor progression and a biomarker of cachexia (Goodrose-Flores et al. 2022, Stares et al. 2021, Lipshitz et al. 2024), rather than low albumin having any direct causative effects on prognosis. The gene discussed is ALB; the disease is Cachexia.